rdf:type |
|
lifeskim:mentions |
umls-concept:C0021467,
umls-concept:C0021469,
umls-concept:C0030685,
umls-concept:C0055688,
umls-concept:C0086418,
umls-concept:C0127400,
umls-concept:C0242599,
umls-concept:C0391871,
umls-concept:C0441655,
umls-concept:C0441712,
umls-concept:C0680255,
umls-concept:C0700624,
umls-concept:C1283071,
umls-concept:C1363844,
umls-concept:C1963578,
umls-concept:C1999216
|
pubmed:issue |
3
|
pubmed:dateCreated |
1987-12-28
|
pubmed:abstractText |
3,7-Dimethoxy-4-phenyl-N-1H tetrazol-5-yl-4H-furo[3,2-b]-indole-2- carboxamide, L-arginate (CI-922) is a potent inhibitory of human neutrophil functions in response to a variety of stimuli. In this report, the effects of CI-922 on specific processes involved in stimulus-response coupling are evaluated. CI-922 does not inhibit human neutrophil phospholipase C or protein kinase C activities. CI-922 is shown to inhibit calmodulin-dependent enzyme activation. The calmodulin antagonist activity is confirmed by calmodulin-Sepharose affinity chromatography. These results suggest that CI-922 inhibits neutrophil activation by preventing the activation of calmodulin-dependent enzymes, implying a critical role for such enzymes in stimulus-response coupling.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0006-291X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
13
|
pubmed:volume |
148
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1110-7
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2825675-Azoles,
pubmed-meshheading:2825675-Calmodulin,
pubmed-meshheading:2825675-Chromatography, Affinity,
pubmed-meshheading:2825675-Humans,
pubmed-meshheading:2825675-Indoles,
pubmed-meshheading:2825675-Neutrophils,
pubmed-meshheading:2825675-Phagocytosis,
pubmed-meshheading:2825675-Phosphatidylinositols,
pubmed-meshheading:2825675-Spectrometry, Fluorescence,
pubmed-meshheading:2825675-Tetrazoles,
pubmed-meshheading:2825675-Type C Phospholipases
|
pubmed:year |
1987
|
pubmed:articleTitle |
Inhibition of human neutrophil activation by the allergic mediator release inhibitor, CI-922: mechanism of inhibitory activity.
|
pubmed:affiliation |
Pharmacology Department, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105.
|
pubmed:publicationType |
Journal Article,
In Vitro
|